Paper8985016
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Jang M and 11 others. Science, 1997. Cited by 3,533 papers, by iCite.
Cite this record
ConductScience Library. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Papers, record 8985016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8985016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticarcinogenic Agents | Major topic |
| Fruit | Major topic |
| Neoplasms, Experimental | Major topic |
| Stilbenes | Major topic |
| Animals | |
| Anti-Inflammatory Agents, Non-Steroidal | |
| Antimutagenic Agents | |
| Carcinogens | |
| Cell Differentiation | |
| Cyclooxygenase 1 | |
| Cyclooxygenase Inhibitors | |
| Female | |
| Humans | |
| Inflammation | |
| Isoenzymes | |
| Mammary Neoplasms, Experimental | |
| Membrane Proteins | |
| Mice | |
| Peroxidases | |
| Precancerous Conditions | |
| Prostaglandin-Endoperoxide Synthases | |
| Rats | |
| Rats, Wistar | |
| Resveratrol | |
| Skin Neoplasms | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 CA48112 | NCI NIH HHS | United States | P01CA048112 | PubMed and NIH |
Source NIH RePORTER
Cited by1,144
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,533 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42968626 | Resveratrol Modulates Bone Metabolism Through SIRT1-Mediated NF-κB Inhibition: Molecular Mechanisms and Therapeutic Implications. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42968626 | PubMed |
| 42940323 | Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study. | Foods | 2026 | https://conductscience.org/library/papers/42940323 | PubMed |
| 42921159 | Natural compounds as potential countermeasures for spaceflight-associated neuro-ocular syndrome. | Front Ophthalmol (Lausanne) | 2026 | https://conductscience.org/library/papers/42921159 | PubMed |
| 42861418 | Alcohol consumption: from biochemistry to behavior, health, and beyond. | Front Toxicol | 2026 | https://conductscience.org/library/papers/42861418 | PubMed |
| 42582115 | Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress. | Front Nutr | 2026 | https://conductscience.org/library/papers/42582115 | PubMed |
| 42555914 | Toxicological and Cytogenetic Screening of Strontium Ranelate Alone and in Combination With Resveratrol. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42555914 | PubMed |
| 42451578 | Natural Source, Chemical Classification and Medicinal Application of the Stilbene-Type Compounds: A Review of Structural Modification Around Stilbene Scaffold. | Molecules | 2026 | https://conductscience.org/library/papers/42451578 | PubMed |
| 42221904 | Research progress on the biosynthesis and regulatory mechanisms of resveratrol in plants. | Front Plant Sci | 2026 | https://conductscience.org/library/papers/42221904 | PubMed |
| 42151413 | Autophagy modulation in cancer. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/42151413 | PubMed |
| 42128977 | Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation. | AAPS J | 2026 | https://conductscience.org/library/papers/42128977 | PubMed |
| 42099748 | Resveratrol for Cancer Radio-Sensitization: Ready for Prime Time or Future Perspective. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42099748 | PubMed |
| 42089408 | Natural xanthones as α-Mangostin induce vasorelaxation involving key gating residues in the S6 domain of BK channels. | Elife | 2026 | https://conductscience.org/library/papers/42089408 | PubMed |
| 42006483 | Resveratrol supplementation as a non-surgical treatment in periodontitis and related systemic conditions. | J Tradit Complement Med | 2026 | https://conductscience.org/library/papers/42006483 | PubMed |
| 42006362 | Thermo-pH dual-responsive nanocarriers enable multiscale-controlled resveratrol release via molecular remodeling and electronic decoupling. | iScience | 2026 | https://conductscience.org/library/papers/42006362 | PubMed |
| 41946701 | A live biohybrid bacterial therapy based on engineered Serratia marcescens. | Nat Commun | 2026 | https://conductscience.org/library/papers/41946701 | PubMed |
| 41924450 | Triphenylphosphonium Bolaamphiphile-Liposomes Loaded with Resveratrol and Trolox: Mitochondriotropic Formulations with Therapeutic Potential in Neurodegeneration and Cancer. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41924450 | PubMed |
| 41828789 | Current State of Knowledge of the Anticancer Properties of Polyphenolic Compounds from Garlic (Allium sativum L.). | Molecules | 2026 | https://conductscience.org/library/papers/41828789 | PubMed |
| 41828721 | Synergistic Anticancer Effects of Vitamin D and Plant-Derived Compounds: Molecular Mechanisms, Therapeutic Potential, and Nanotechnology-Enabled Delivery Approaches. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828721 | PubMed |
| 41782655 | An Updated Narrative Review on the Therapeutic Potential of Resveratrol in the Treatment of Cancer. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41782655 | PubMed |
| 41750262 | Phytochemicals Possess Selective Chemopreventive Mechanisms That Safeguard Human Cells from Oxidative Toxicity. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750262 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PTGS1 | 5742 | PubTator's text mining | https://conductscience.org/library/genes/5742 | NCBI Gene |
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8985016
GET https://conductscience.org/api/papers/v1/8985016/cited_by?page=2